Table 4 Adverse events
Edoxaban 15 mg (n = 23) | Edoxaban 30 mg (n = 209) | p value | OR (95% CI) | |
|---|---|---|---|---|
Major bleeding | 0 | 0 | 1.00 | |
CRNM bleeding | 0 | 2 (1%) | 1.00 | |
Minor bleeding | 0 | 7 (3.3%) | 1.00 | |
AST or ALT level ≥ 1.5 × ULN | 4 (17.4%) | 26 (12.4%) | 0.51 | 1.48 (0.34–4.95) |
AST or ALT level ≥ 3 × ULN | 3 (13.0%) | 14 (6.7%) | 0.39 | 2.07 (0.35–8.37) |